Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2. J Cardiovasc Pharmacol • June 10, 2020
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19). J Cardiovasc Pharmacol • May 20, 2020
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. J Cardiovasc Pharmacol • February 5, 2016
Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction. J Cardiovasc Pharmacol • May 19, 2009
The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation. J Cardiovasc Pharmacol • December 23, 2008